N-Methylsansalvamide

a cytotoxic cyclic depsipeptide from a marine fungus of the genus Fusarium; structure in first source

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/07/2021 - "Here, we explored the anti-tumor efficacy of a cyclic pentadepsipeptide, N-methylsansalvamide (MSSV), in bladder cancer. "
2.	Urinary Bladder Neoplasms (Bladder Cancer) 01/07/2021 - "A Novel Cyclic Pentadepsipeptide, N-Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer." 01/07/2021 - "Here, we explored the anti-tumor efficacy of a cyclic pentadepsipeptide, N-methylsansalvamide (MSSV), in bladder cancer. "
3.	Colonic Neoplasms (Colon Cancer) 01/01/2023 - "N-methylsansalvamide elicits antitumor effects in colon cancer cells in vitro and in vivo by regulating proliferation, apoptosis, and metastatic capacity."